News

A recent study reveal that some supplement companies may mislead customers with unproven health claims and undeclared ingredients.

Preclinical studies of a new gene therapy show it can eliminate 90% or more of herpes infection and suppress how much virus can be released by an individual.

A new study suggests the need for personalized approaches to supplementation to help reduce vitamin D deficiency, which remains widespread despite extensive research.

Pairing a personalized dendritic cell vaccine with an immune-boosting compound improves the immune response to malignant gliomas.

CAR T-cell therapy could be adapted to target solid tumors, potentially transforming cancer treatment.

Many vaccines, including the Novavax COVID-19 vaccine, contain adjuvants that stimulate the immune system to mount a stronger defense. Producing one such adjuvant in yeast promises to make it less expensive and more widely available.

A major clinical trial has found that an additional COVID-19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against the virus.

Results from a clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

A biomaterial vaccine enhances and sustains lymph node expansion following vaccination, boosting anti-tumor immunity in an animal model.

A meta-analysis of trials testing psilocybin-based treatments for depression has "encouraging" results. Here, we speak with the co-author of the study to learn more about how it was conducted, the key findings and implications for clinical implementation of psychedelic-based treatments.